We are live on ! Find out more

5 hedge funds and large institutions have $755K invested in Daxor in 2022 Q1 according to their latest regulatory filings, with 1 funds opening new positions, 2 increasing their positions, 0 reducing their positions, and 2 closing their positions.

New
Increased
Maintained
Reduced
Closed

0.51% less ownership

Funds ownership: 2.26% → 1.76% (-0.51%)

17% less funds holding

Funds holding: 6 → 5 (-1)

27% less capital invested

Capital invested by funds: $1.03M → $755K (-$274K)

50% less first-time investments, than exits

New positions opened: 1 | Existing positions closed: 2

Holders
5
Holders Change
-1
Holders Change %
-16.67%
% of All Funds
0.08%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
1
Increased
2
Reduced
–
Closed
2
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

DXR Hedge Fund Activity: Q1 2022 in Review

5 of the 6,361 institutional investors tracked by Wall St. Rank reported a position in Daxor (DXR) for Q1 2022, worth a combined $755K — down 27% from $1.03M a quarter earlier.

Sellers outnumbered buyers: 2 funds closed out of DXR and 1 opened new positions — a net loss of 1 holder — while 0 trimmed existing stakes and 2 added.

The largest buyer was Renaissance Technologies, adding an estimated $6.58K. The largest seller was Sabby Management, exiting entirely with an estimated $237K sold.

  • 5 institutional investors held Daxor (DXR) as of Q1 2022, down from 6 in Q4 2021.
  • Funds reported $755K of Daxor stock for Q1 2022, down 27% quarter-over-quarter.
  • 1 fund opened new Daxor positions in Q1 2022 and 2 closed out, a net change of -1 holder.
  • The largest Daxor buyer in Q1 2022 was Renaissance Technologies, an estimated $6.58K added.
  • The largest Daxor seller in Q1 2022 was Sabby Management, an estimated $237K sold.

Based on aggregated 13F filings for Q1 2022.